Facebook Twitter LinkedIn Google Plus RSS

Princeton-based Soligenix gets FDA boost for drug to treat chemotherapy side effect Source: The Star-Ledger

More than 80 percent of patients who undergo radiation therapy for throat, nose and mouth cancer develop a painful tissue swelling that can lead to infection. Nearly half of the people who receive chemotherapy for the same diseases are also affected.

Continue Reading »»

More From This Industry

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy